PA
ALBO
Perceptive Advisors’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,757,160
| Closed | -$38M | – | 112 |
|
|
2022
Q4 | $38M | Sell |
1,757,160
-602,979
| -26% | -$13M | 1.07% | 26 |
|
|
2022
Q3 | $45.7M | Hold |
2,360,139
| – | – | 1.33% | 23 |
|
|
2022
Q2 | $46.9M | Hold |
2,360,139
| – | – | 1.47% | 16 |
|
|
2022
Q1 | $70.4M | Hold |
2,360,139
| – | – | 1.41% | 20 |
|
|
2021
Q4 | $55M | Hold |
2,360,139
| – | – | 0.85% | 31 |
|
|
2021
Q3 | $73.6M | Hold |
2,360,139
| – | – | 1.07% | 26 |
|
|
2021
Q2 | $83M | Hold |
2,360,139
| – | – | 1.08% | 25 |
|
|
2021
Q1 | $83.2M | Hold |
2,360,139
| – | – | 1.05% | 23 |
|
|
2020
Q4 | $88.5M | Hold |
2,360,139
| – | – | 0.95% | 29 |
|
|
2020
Q3 | $78.8M | Buy |
2,360,139
+400,000
| +20% | +$13.3M | 1.15% | 22 |
|
|
2020
Q2 | $51.9M | Hold |
1,960,139
| – | – | 0.84% | 30 |
|
|
2020
Q1 | $31.9M | Buy |
1,960,139
+255,809
| +15% | +$4.17M | 0.83% | 28 |
|
|
2019
Q4 | $43.3M | Hold |
1,704,330
| – | – | 0.86% | 28 |
|
|
2019
Q3 | $34.1M | Hold |
1,704,330
| – | – | 0.92% | 29 |
|
|
2019
Q2 | $54.9M | Hold |
1,704,330
| – | – | 1.26% | 18 |
|
|
2019
Q1 | $54.9M | Hold |
1,704,330
| – | – | 1.55% | 20 |
|
|
2018
Q4 | $39.5M | Hold |
1,704,330
| – | – | 1.5% | 22 |
|
|
2018
Q3 | $56.2M | Hold |
1,704,330
| – | – | 1.5% | 22 |
|
|
2018
Q2 | $60.5M | Hold |
1,704,330
| – | – | 1.59% | 16 |
|
|
2018
Q1 | $55.5M | Buy |
1,704,330
+384,330
| +29% | +$12.5M | 1.55% | 19 |
|
|
2017
Q4 | $33.8M | Buy |
1,320,000
+475,000
| +56% | +$12.2M | 1.12% | 22 |
|
|
2017
Q3 | $17.7M | Hold |
845,000
| – | – | 0.68% | 35 |
|
|
2017
Q2 | $17.4M | Buy |
+845,000
| New | +$17.4M | 0.88% | 32 |
|